Maxitrol Ointment
Product Images NDC 0078-0771

5 FDA label images from Novartis Pharmaceuticals Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Maxitrol (NDC 0078-0771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure For The Active Ingredient Neomycin Sulfate (Maxitrol Ointment 01)

The Chemical Structure For The Active Ingredient Neomycin Sulfate (Maxitrol Ointment 01)
Chemical structure of neomycin sulfate, the active ingredient in MAXITROL ophthalmic ointment.*
FDA Label Image

The Chemical Structure For The Active Ingredient Polymyxin B Sulfate (Maxitrol Ointment 02)

The Chemical Structure For The Active Ingredient Polymyxin B Sulfate (Maxitrol Ointment 02)
Chemical structure of the active ingredient neomycin sulfate. The diagram shows the molecular arrangement including amino groups (γ-NH2), L-DAB, and other amino acid residues, illustrating the detailed structure of neomycin sulfate.*
FDA Label Image

Polymyxin-text (Maxitrol Ointment 03)

Polymyxin-text (Maxitrol Ointment 03)
Chemical structure diagram showing the molecular components of Polymyxin B1, Polymyxin B2 with their R groups specified, and DAB (a, y-diaminobutyric acid). This image illustrates the chemical composition related to the active ingredient Polymyxin B in MAXITROL ointment.*
FDA Label Image

The Chemical Structure For The Active Ingredient Dexamethasone (Maxitrol Ointment 04)

The Chemical Structure For The Active Ingredient Dexamethasone (Maxitrol Ointment 04)
Chemical structure of dexamethasone, one of the active ingredients in MAXITROL ophthalmic ointment. The diagram shows the molecular formula with carbon, hydrogen, oxygen, and fluorine atoms arranged in the steroid backbone characteristic of dexamethasone.*
FDA Label Image

Ndc 0078-0771-01 Maxitrol® (neomycin And Polymyxin B Sulfates And Dexamethasone Ophthalmic Ointment) Sterile 3.5 G Net Wt. Rx Only Novartis (Maxitrol Ointment 05)

Ndc 0078-0771-01        Maxitrol®        (neomycin And Polymyxin B        Sulfates And Dexamethasone        Ophthalmic Ointment)        Sterile 3.5 G Net Wt.        Rx Only        Novartis (Maxitrol Ointment 05)
MAXITROL ophthalmic ointment containing neomycin sulfate, polymyxin B sulfate, and dexamethasone, sterile 3.5 g net weight. The yellow carton shows the brand and generic names, NDC 0078-0771-01, and the Novartis Pharmaceuticals Corporation labeler. Manufactured in Belgium and distributed by Novartis in East Hanover, NJ, the package includes barcodes and typical drug information warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.